Morocco vs Tonga: Cause of death, by non-communicable diseases, ages 5-14, female
Morocco
47.6%
in 2021
Tonga
47.3%
in 2021
Morocco rank
66th
Tonga rank
67th
Cause of death, by non-communicable diseases, ages 5-14, female over time
- Morocco
- Tonga
How they compare
Morocco currently reports 47.6% against 47.3% in Tonga, a difference of 0.3%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Tonga ahead.
Morocco ranks 66th and Tonga ranks 67th of 184 countries.
Across the 3 decades both report, Morocco averaged higher in 1 and Tonga in 2.
Head to head by decade
| Decade | Morocco | Tonga | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 23.6% | 38.9% | 15.3% | Tonga |
| 2010s | 43.6% | 44.9% | 1.3% | Tonga |
| 2020s | 47.1% | 47.0% | 0.0% | Morocco |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, female, Morocco or Tonga?
- Morocco, at 47.6% against 47.3% in Tonga as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, female between Morocco and Tonga?
- 0.3%, with Morocco ahead.
- How many years of comparable data are there for Morocco and Tonga?
- 6 years are reported by both, from 2000 to 2021.
- How do Morocco and Tonga rank globally for cause of death, by non-communicable diseases, ages 5-14, female?
- Morocco ranks 66th and Tonga ranks 67th of 184 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, female (% of total female deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 5-14 due to non-communicable diseases divided by number of all female deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.